Drug Discovery and Telemedicine : Through Artificial Intelligence, Computer Vision, and IoT

Idioma: inglés

Editorial: De Gruyter, 2025

3111503984 / 9783111503981

  • Tapa blanda
  • Nuevo
Ver todos los detalles

Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

Vendedor de 5 estrellas

Vendedor de IberLibro desde 14 de agosto de 2006

Tapa blanda

Condición: Nuevo

EUR 134,40

Envío por EUR 35,00 
Se envía de Alemania a Estados Unidos de America

Cantidad disponible: 1 disponible

Añadir al carrito
Devoluciones gratuitas de 30 días

Descripción del artículo del vendedor

Neuware - Our proposed book emerges in response to the critical need for an interdisciplinary resource that encapsulates the burgeoning role of artificial intelligence (AI) in reshaping drug discovery and telemedicine. As these sectors witness transformative changes driven by AI technologies, there's a pressing demand for a comprehensive guide that navigates through these advancements, offering insights, methodologies, and practical applications to professionals at the forefront of healthcare and pharmaceutical research. At its core, the book delves into the intricate ways in which AI and machine learning algorithms are being harnessed to streamline the drug development process, from initial discovery through to clinical trials, and how these technologies are concurrently revolutionizing the delivery of healthcare services via telemedicine. Specific focus areas include the application of deep learning in identifying novel drug candidates, AI-driven predictive models for pharmacokinetics and pharmacodynamics, automation in laboratory research, and the integration of AI in diagnostic processes, personalized medicine, and patient monitoring systems. Each chapter not only explores current state-of-the-art methodologies and case studies but also critically examines challenges, such as data privacy, ethical considerations, and the need for robust, interpretable models that can be trusted by healthcare professionals and patients alike. Furthermore, the book places a strong emphasis on the synergistic potential of combining AI with telemedicine, illustrating how these technologies can expand access to healthcare, improve the accuracy of remote diagnoses, and enable continuous, data-driven patient care. By providing a panoramic view of current trends, technological innovations, and future directions, the book aims to serve as a pivotal reference for scientists, researchers, clinicians, and policymakers involved in drug discovery and healthcare delivery. In conclusion, this book stands as an essential compendium for specialists seeking to navigate the complexities and harness the opportunities presented by AI in the pharmaceutical and healthcare industries. It offers a critical, in-depth exploration of the transformative impact of AI technologies, underscoring their relevance and potential to dramatically enhance drug discovery and telemedicine practices. This publication not only equips its target audience with the knowledge to lead innovation in their fields but also engages with the broader ethical, social, and practical implications of AI, making it an invaluable resource for advancing towards more effective, efficient, and accessible healthcare solutions. The book is significant for several reasons: Interdisciplinary Appeal: It serves as a critical resource for professionals and researchers across the fields of computer science, pharmaceutical sciences, and healthcare, facilitating a deeper understanding of AI's potential and fostering interdisciplinary collaborations. Innovation in Drug Discovery: By highlighting novel AI methodologies in drug discovery, the book offers insights into how these technologies can shorten the development timelines, reduce costs, and increase the success rates of new therapies, which is crucial for addressing unmet medical needs. Revolutionizing Telemedicine: The detailed discussion on AI's role in telemedicine illustrates how these advancements can enhance access to healthcare, improve the quality of care, and make healthcare systems more efficient, especially in remote and underserved areas. Ethical and Regulatory Considerations: It likely addresses the ethical, privacy, and regulatory challenges associated with implementing AI in healthcare, offering guidelines for navigating these complexities while maximizing patient benefits. Future Directions: By e.…

Título
Drug Discovery and Telemedicine : Through Artificial Intelligence, Computer Vision, and IoT
Autor
Saurav Mallik
Editorial
De Gruyter
Año de publicación
2025
Estado
Neu
Encuadernación
Taschenbuch
Idioma
inglés
ISBN 10
3111503984
ISBN 13
9783111503981
Peso del artículo
491 gramos
Dimensiones
242x170x15 mm

AHA-BUCH GmbH

Einbeck, Alemania

Vendedor de 5 estrellas

Vendedor de IberLibro desde 14 de agosto de 2006

Tarifas de envío de Alemania a Estados Unidos de America

ArtículoDe 7 a 10 días hábilesDe 5 a 7 días hábiles
Primer artículoEUR 35,00EUR 45,00
Los plazos de entrega los establecen los vendedores y varían según el transportista y la ubicación. Los pedidos que pasan por la aduana pueden sufrir retrasos y los compradores son responsables de los aranceles o tarifas asociadas. Los vendedores pueden ponerse en contacto con usted en relación con cargos adicionales para cubrir cualquier aumento en los costes de envío de los artículos.

Métodos de pago

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay
  • Cheque
  • Giro bancario
  • PayPal

Descripción de la tienda

Das Unternehmen AHA-BUCH GmbH: Seit der Gründung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisgünstig wie möglich ihren Bücherwunsch zu erfüllen. Unsere Firma beschäftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine Wünsche! Auf über 3700 m2 Fläche haben wir über 100.000 Bücher, Modernes Antiquariat und Spiele auf Lager.

Especialidad

Kinderbücher & Kinderhör Casetten, German Books, Software, Natur & Tiere, Ratgeber, Sachbücher, Englische Bücher, Medizin & Gesundheit, Universität & Studium

Información empresarial del vendedor

AHA-BUCH GmbH

Garlebsen 48
Einbeck, Alemania 37574

IImprint

Información del vendedor

AHA-BUCH GmbH
representado por el director gerente Christel Glass
Garlebsen 48
37574 Einbeck
Alemania
Teléfono: 055639996039
Fax: 055639995974
E-Mail: abebooks@aha-buch.de
USt-IdNr.: DE261904229
Inscrita en el Registro Mercantil Amtsgerichtes Göttingen
Handelsregisternummer HRB 200691

Resolución alternativa de conflictos:
La Comisión Europea proporciona una plataforma para la resolución extrajudicial de litigios en línea (plataforma ODR), a la que se puede acceder en https://ec.europa.eu/odr.

Somos miembros de la iniciativa "FairCommerce" desde el 25.05.2018.
Para obtener más información, consulte www.fair-commerce.de.